Background Currently, T-cell based gamma interferon (IFNγ) release assays (IGRAs) are acknowledged as the best methods available for the screening of latent tuberculosis infection (LTBI) and also as aid for the diagnosis of active tuberculosis (TB). To our information, the performance of these diagnostic tests has not been evaluated in Ethiopia. Therefore, the intent of this study was to evaluate the performance of QuantiFERON-TB Gold In-Tube (QFTGIT) in patients clinically suspected of active pulmonary TB (PTB) as well as in healthy subjects prior to its utilization for the epidemiological study of active TB and LTBI in Afar pastoralists. Methods The sensitivity ...
Aim: To determine whether QuantiFERONH-TB Gold In-Tube (QFT) can contribute to the diagnosis of acti...
<div><h3>Aim</h3><p>To determine whether QuantiFERON®-TB Gold In-Tube (QFT) can contribute to the di...
As part of a formal evaluation of the Quantiferon-Gold in-tube assay (QFT-IT) for latent TB infectio...
Abstract Background In settings with low background prevalence of tuberculosis (TB) infection, inter...
Abstract Objective To determine the performance of QuantiFERON-TB IN-Gold for the diagnosis active t...
Interferon-gamma (IFN-γ) release assays have improved latent tuberculosis (TB) detection and have be...
BACKGROUND: The utility of QuantiFERON-TB Gold In-Tube (QFT-G) test in the diagnosis of tuberculosis...
Background Interferon-gamma (IFN-γ) Release Assays (IGRA) are more specific than the tuberculosis sk...
The value of QuantiFERON in the diagnosis of tuberculosis disease and in the monitoring of the respo...
Tuberculosis (TB) is the second leading cause of death from an infectious disease worldwide and rema...
BACKGROUND: Interferon-gamma (IFN-gamma) release assays (IGRAs), such as the QuantiFERON-TB Gold In-...
Objective/Background: Introduction of the interferon gamma (IFN-gamma) release assays with their hig...
Abstract Background There is little information concerning community-based prevalence of latent tube...
WOS: 000402308400002PubMed ID: 28566075The aims of this study were to evaluate the sensitivity of Qu...
Background QuantiFERON-TB Gold In-Tube® (QFT-GIT) test is used for the diagnosis of ...
Aim: To determine whether QuantiFERONH-TB Gold In-Tube (QFT) can contribute to the diagnosis of acti...
<div><h3>Aim</h3><p>To determine whether QuantiFERON®-TB Gold In-Tube (QFT) can contribute to the di...
As part of a formal evaluation of the Quantiferon-Gold in-tube assay (QFT-IT) for latent TB infectio...
Abstract Background In settings with low background prevalence of tuberculosis (TB) infection, inter...
Abstract Objective To determine the performance of QuantiFERON-TB IN-Gold for the diagnosis active t...
Interferon-gamma (IFN-γ) release assays have improved latent tuberculosis (TB) detection and have be...
BACKGROUND: The utility of QuantiFERON-TB Gold In-Tube (QFT-G) test in the diagnosis of tuberculosis...
Background Interferon-gamma (IFN-γ) Release Assays (IGRA) are more specific than the tuberculosis sk...
The value of QuantiFERON in the diagnosis of tuberculosis disease and in the monitoring of the respo...
Tuberculosis (TB) is the second leading cause of death from an infectious disease worldwide and rema...
BACKGROUND: Interferon-gamma (IFN-gamma) release assays (IGRAs), such as the QuantiFERON-TB Gold In-...
Objective/Background: Introduction of the interferon gamma (IFN-gamma) release assays with their hig...
Abstract Background There is little information concerning community-based prevalence of latent tube...
WOS: 000402308400002PubMed ID: 28566075The aims of this study were to evaluate the sensitivity of Qu...
Background QuantiFERON-TB Gold In-Tube® (QFT-GIT) test is used for the diagnosis of ...
Aim: To determine whether QuantiFERONH-TB Gold In-Tube (QFT) can contribute to the diagnosis of acti...
<div><h3>Aim</h3><p>To determine whether QuantiFERON®-TB Gold In-Tube (QFT) can contribute to the di...
As part of a formal evaluation of the Quantiferon-Gold in-tube assay (QFT-IT) for latent TB infectio...